A new trading day began on Thursday, with Dyne Therapeutics Inc (NASDAQ: DYN) stock price up 4.34% from the previous day of trading, before settling in for the closing price of $7.83. DYN’s price has ranged from $6.36 to $47.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -5.63%. With a float of $87.73 million, this company’s outstanding shares have now reached $102.32 million.
Let’s look at the performance matrix of the company that is accounted for 191 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Dyne Therapeutics Inc (DYN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dyne Therapeutics Inc is 22.80%, while institutional ownership is 81.32%. The most recent insider transaction that took place on Mar 13 ’25, was worth 1,733. In this transaction Chief Commercial Officer of this company sold 143 shares at a rate of $12.12, taking the stock ownership to the 96,057 shares. Before that another transaction happened on Mar 11 ’25, when Company’s SVP, Head of Finance & Admin. sold 1,343 for $11.38, making the entire transaction worth $15,283. This insider now owns 122,330 shares in total.
Dyne Therapeutics Inc (DYN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -5.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.20% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Here are Dyne Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 15.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.35, a number that is poised to hit -0.85 in the next quarter and is forecasted to reach -3.69 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc (NASDAQ: DYN) saw its 5-day average volume 1.56 million, a negative change from its year-to-date volume of 2.27 million. As of the previous 9 days, the stock’s Stochastic %D was 60.81%. Additionally, its Average True Range was 0.86.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 7.25%, which indicates a significant decrease from 39.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 121.81% in the past 14 days, which was higher than the 91.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.61, while its 200-day Moving Average is $26.83. Nevertheless, the first resistance level for the watch stands at $8.40 in the near term. At $8.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.03. If the price goes on to break the first support level at $7.77, it is likely to go to the next support level at $7.36. The third support level lies at $7.14 if the price breaches the second support level.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
With a market capitalization of 928.39 million, the company has a total of 113,634K Shares Outstanding. Currently, annual sales are 0 K while annual income is -317,420 K. The company’s previous quarter sales were 0 K while its latest quarter income was -89,540 K.
